Web7 rows · Apr 6, 2024 · Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 ... WebApr 10, 2024 · According to 33 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 88.13 , which predicts an increase of 94.85%. The lowest target is $ 39.39 and the highest is $ 231. On average, analysts rate CRSP stock as a buy. Analyst Consensus: Buy Analyst Ratings
CRISPR Therapeutics Stock (NASDAQ:CRSP), Analyst …
WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. … Web2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... davidson college biology major
CRSP CRISPR Therapeutics AG Analyst Estimates MarketWatch
WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. Web23 hours ago · The analyst sees a lot of momentum to come back into this stock, starting with the ongoing exa-cel regulatory review. Price Action: CRSP shares are up 15.50% at $50.22 on the last check Thursday. WebCRSP will report Q1 2024 earnings on 05/09/2024 EPS Surprise Estimate Actual Q1 2024 Q2 2024 Q3 2024 Q4 2024 -3 -2 -1 Analyst Ratings Upgrades/Downgrades View All Upgrades & Downgrades FY... gastonia north carolina building permits